# Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects

> **NCT00666627** · PHASE2 · COMPLETED · sponsor: **Sheffield Teaching Hospitals NHS Foundation Trust** · enrollment: 410 (estimated)

## Conditions studied

- Post-menopausal Osteoporosis

## Interventions

- **DRUG:** Ibandronate
- **DRUG:** Risedronate
- **DRUG:** Alendronate

## Key facts

- **NCT ID:** NCT00666627
- **Lead sponsor:** Sheffield Teaching Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2012-09
- **Final completion:** 2014-12
- **Target enrollment:** 410 (ESTIMATED)
- **Last updated:** 2018-03-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00666627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00666627, "Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT00666627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*